Edgestream Partners’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-64,009
Closed -$7.31M 876
2025
Q1
$7.31M Buy
+64,009
New +$7.31M 0.25% 112
2024
Q3
Sell
-23,516
Closed -$764K 873
2024
Q2
$764K Sell
23,516
-36,775
-61% -$1.19M 0.04% 584
2024
Q1
$1.52M Buy
+60,291
New +$1.52M 0.08% 406
2023
Q3
Sell
-28,788
Closed -$641K 836
2023
Q2
$641K Buy
+28,788
New +$641K 0.06% 474